Cargando…

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: Biomarkers have the potential to guide treatment selection and clinical care in metastatic renal cell carcinoma (mRCC) in an expanding treatment landscape. We report baseline neutrophil-to-eosinophil ratios (NER) in patients with mRCC treated with immune checkpoint inhibitors (CPIs) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Tony Z, Ravindranathan, Deepak, Liu, Yuan, Martini, Dylan J, Brown, Jacqueline T, Nazha, Bassel, Russler, Greta, Yantorni, Lauren B, Caulfield, Sarah, Carthon, Bradley C, Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Gastrointestinal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020802/ https://www.ncbi.nlm.nih.gov/pubmed/36427017 http://dx.doi.org/10.1093/oncolo/oyac236

Ejemplares similares

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
por: Brown, Jacqueline T, et al.
Publicado: (2021)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
por: Olsen, T. Anders, et al.
Publicado: (2021)

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2021)

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
por: Martini, Dylan J., et al.
Publicado: (2022)

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2019)

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
por: Shabto, Julie M., et al.
Publicado: (2020)

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma
por: Nazha, Bassel, et al.
Publicado: (2022)

Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
por: Olsen, T. Anders, et al.
Publicado: (2022)

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Inflammatory Markers in Cancer Immunotherapy
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature
por: Ravindranathan, Deepak, et al.
Publicado: (2018)

Mediastinal extension of a pancreatic pseudocyst
por: Omer, Adil, et al.
Publicado: (2018)

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report
por: Bilen, Mehmet A., et al.
Publicado: (2021)

Undifferentiated embryonal sarcoma of liver: Paradoxical imaging appearance
por: Thombare, Pranav, et al.
Publicado: (2020)

Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma
por: Martini, Dylan J., et al.
Publicado: (2021)

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus
por: Master, Viraj A., et al.
Publicado: (2022)

Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer
por: Thawani, Rajat, et al.
Publicado: (2023)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT
por: Bilen, Mehmet Asim, et al.
Publicado: (2022)

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
por: Carlisle, Jennifer Wilkinson, et al.
Publicado: (2022)

Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature Review
por: Smith, Katherine Emilie Rhoades, et al.
Publicado: (2020)

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience
por: Serpas Higbie, Victoria, et al.
Publicado: (2022)

BRAF (V600E)/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Colle, Raphael, et al.
Publicado: (2023)

Local staging of rectal cancer: the current role of MRI
por: Klessen, Christian, et al.
Publicado: (2006)

New coil concept for endoluminal MR imaging: Initial results in staging of gastric carcinoma in correlation with Histopathology
por: Heye, Tobias, et al.
Publicado: (2006)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

Feasibility study of computed tomography colonography using limited bowel preparation at normal and low-dose levels study
por: Florie, Jasper, et al.
Publicado: (2007)

CT colonography: optimisation, diagnostic performance and patient acceptability of reduced-laxative regimens using barium-based faecal tagging
por: Taylor, Stuart A., et al.
Publicado: (2007)

Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis
por: de Haan, Margriet C., et al.
Publicado: (2011)

Small Bowel Obstruction from Capsule Endoscopy
por: Boysen, Megan, et al.
Publicado: (2010)

Boerhaave’s Syndrome
por: Smith, J. Shaun, et al.
Publicado: (2010)

Polyp measurement based on CT colonography and colonoscopy: variability and systematic differences
por: de Vries, Ayso H., et al.
Publicado: (2009)

Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies
por: Zijta, Frank M., et al.
Publicado: (2009)

Profiles of US and CT imaging features with a high probability of appendicitis
por: van Randen, A., et al.
Publicado: (2010)

Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience
por: Zhao, Jun-Gong, et al.
Publicado: (2009)

Primary uncleansed 2D versus primary electronically cleansed 3D in limited bowel preparation CT-colonography. Is there a difference for novices and experienced readers?
por: de Vries, Ayso H., et al.
Publicado: (2009)

Delayed Presentation of Sigmoid Volvulus in a Young Woman
por: Weingrow, Daniel, et al.
Publicado: (2012)

Right-Sided Sigmoid Diverticular Perforation
por: Little, Andrew, et al.
Publicado: (2012)

Massive Gastric Distension from Chronic Intestinal Pseudo-Obstruction
por: DeNazareth, Andrew G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2u426h0752ptc6mbmjb5a15ber